Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.
Alastair B
AB
Law
Gail
G
Ryan
Stephen
S
Lade
H Miles
HM
Prince
D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005871:Castleman Disease / Q000188:drug therapy* / Q000276:immunology; D018023:HIV Seronegativity; D019288:Herpesvirus 8, Human / Q000302:isolation & purification; D006801:Humans; D008297:Male; D012074:Remission Induction; D000069283:Rituximab; D012514:Sarcoma, Kaposi / Q000175:diagnosis* / Q000276:immunology / Q000821:virology*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab